Standout Papers

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inh... 2012 2026 2016 2021 489
  1. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer (2012)
    Andrew Weickhardt, Benjamin Scheier et al. Journal of Thoracic Oncology

Immediate Impact

1 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
8 intermediate papers

Works of Benjamin Scheier being referenced

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
2012 Standout
Continuation of EGFR/ALK inhibition after local therapy of oligoprogressive disease in EGFR mutant (Mt) and ALK+ non-small cell lung cancer (NSCLC).
2012
and 1 more

Author Peers

Author Last Decade Papers Cites
Benjamin Scheier 531 627 126 6 716
Lara Buchmiller 359 277 179 7 594
D. Brisgand 628 656 155 8 829
A Yódice 377 380 224 4 726
Y. Nakanishi 230 435 109 7 608
Krikor Bornazyan 688 464 40 7 808
Jessamy A. Boyd 311 575 70 10 706
KEIICHI SUEMASU 221 498 87 8 638
Colin Trask 537 480 158 12 825
Karin Mattson 267 288 298 10 622
Peter C. Ungaro 460 244 74 12 778

All Works

Loading papers...

Rankless by CCL
2026